| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0084 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0097 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0093 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |